| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | John P. Lydon | Q90976640 |
| P2093 | author name string | Rodrigo Fernandez-Valdivia | |
| P2860 | cites work | Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse | Q24315716 |
| Central control of fever and female body temperature by RANKL/RANK | Q24321735 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer | Q24605866 | ||
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 | ||
| RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis | Q28294501 | ||
| IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development | Q28508430 | ||
| Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation | Q28575953 | ||
| The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse | Q28585870 | ||
| Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform | Q28586470 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development | Q28593949 | ||
| Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling | Q28594185 | ||
| Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
| The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway | Q29615176 | ||
| Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities | Q29615568 | ||
| Generation of a functional mammary gland from a single stem cell | Q29616496 | ||
| Purification and unique properties of mammary epithelial stem cells | Q29616497 | ||
| In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells | Q29616498 | ||
| Cells of origin in cancer | Q29619557 | ||
| Unlimited division potential of precancerous mouse mammary cells after spontaneous or carcinogen-induced transformation | Q33226918 | ||
| Wnt4 is not sufficient to induce lobuloalveolar mammary development | Q33514113 | ||
| Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model | Q33517133 | ||
| Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. | Q33733718 | ||
| Common mechanisms of osteosarcoma and Paget's disease | Q33746136 | ||
| Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene | Q33887784 | ||
| Hormonal contraception and chemoprevention of female cancers | Q33973994 | ||
| Mammary gland development and tumorigenesis in estrogen receptor knockout mice | Q33997388 | ||
| Breast cancer and hormone-replacement therapy in the Million Women Study | Q34223870 | ||
| HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis | Q34242741 | ||
| Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. | Q34281611 | ||
| Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2 | Q34302372 | ||
| Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling | Q35194008 | ||
| NF-kappaB in mammary gland development and breast cancer | Q35592117 | ||
| Steroid receptors and proliferation in the human breast. | Q35605004 | ||
| RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini | Q35641868 | ||
| A paracrine role for the epithelial progesterone receptor in mammary gland development | Q36064196 | ||
| Pregnancy and stem cell behavior | Q36123672 | ||
| Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy | Q36290284 | ||
| Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. | Q36366450 | ||
| The RANK/RANKL/OPG triad in cancer-induced bone diseases | Q36688664 | ||
| Challenges to defining a role for progesterone in breast cancer | Q36786766 | ||
| Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial | Q36851595 | ||
| Transcriptional response of the murine mammary gland to acute progesterone exposure | Q37034915 | ||
| DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast | Q37244666 | ||
| Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis | Q37426789 | ||
| Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women | Q37480990 | ||
| Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis | Q39740475 | ||
| RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis | Q39964150 | ||
| Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist | Q40202330 | ||
| Regulation of cancer cell migration and bone metastasis by RANKL. | Q40298349 | ||
| Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells | Q40638246 | ||
| Osteoprotegerin ligand induces beta-casein gene expression through the transcription factor CCAAT/enhancer-binding protein beta | Q40765947 | ||
| Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus | Q40820746 | ||
| Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk | Q40862149 | ||
| Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin | Q41719517 | ||
| RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla | Q41868543 | ||
| Progesterone induces adult mammary stem cell expansion | Q42471079 | ||
| Steroid hormone receptor status of mouse mammary stem cells | Q42498451 | ||
| Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling | Q42570912 | ||
| Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study | Q42829926 | ||
| Control of mammary stem cell function by steroid hormone signalling. | Q43103606 | ||
| A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development. | Q44196804 | ||
| Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro | Q44198306 | ||
| Hormone dependence in premalignant mammary progression. | Q44342323 | ||
| Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk | Q44507925 | ||
| Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. | Q45943068 | ||
| Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target | Q46344166 | ||
| Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo | Q47616899 | ||
| Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. | Q51803777 | ||
| Prolactin controls mammary gland development via direct and indirect mechanisms. | Q52176529 | ||
| Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. | Q52214583 | ||
| A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. | Q52251850 | ||
| Landmark article Sept 8, 1923. An ovarian hormone. Preliminary report on its localization, extraction and partial purification, and action in test animals. By Edgar Allen and Edward A. Doisy | Q52409568 | ||
| Dissociation between steroid receptor expression and cell proliferation in the human breast. | Q52528046 | ||
| AN OVARIAN HORMONE | Q56170543 | ||
| On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases | Q58724195 | ||
| Transient Increase in the Risk of Breast Cancer after Giving Birth | Q59265488 | ||
| Classic pages in obstetrics and gynecology: George W. Corner and Willard M. Allen. Physiology of the corpus luteum. II. Production of a special uterine reaction (progestational proliferation) by extracts of corpus luteum | Q69904938 | ||
| Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies | Q70728804 | ||
| Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast | Q73276429 | ||
| An entire functional mammary gland may comprise the progeny from a single cell | Q74460847 | ||
| Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function | Q78257311 | ||
| Endocrine control of mammarygland development and function in the C3H/ He Crgl mouse | Q78480627 | ||
| Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice | Q78693141 | ||
| Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland | Q79818790 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 91-100 | |
| P577 | publication date | 2011-09-22 | |
| P1433 | published in | Molecular and Cellular Endocrinology | Q1573600 |
| P1476 | title | From the ranks of mammary progesterone mediators, RANKL takes the spotlight | |
| P478 | volume | 357 |
| Q35703504 | A model for breast cancer risk based on stem-cell theory |
| Q35659971 | Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors |
| Q57796276 | Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL) and Mammographic Density in Premenopausal Women |
| Q34549156 | Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk. |
| Q34621664 | Early pregnancy sex steroids and maternal breast cancer: a nested case-control study |
| Q27003345 | Mammary stem cells and the differentiation hierarchy: current status and perspectives |
| Q38155200 | Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis |
| Q90397955 | New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity |
| Q90631432 | Origins of Alterations to Rankl Null Mutant Mouse Dental Root Development |
| Q37240573 | Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth |
| Q37249108 | Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells |
| Q42376272 | Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action |
| Q39670403 | RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. |
| Q34263429 | Role of stem cells in human uterine leiomyoma growth |
| Q33768390 | The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1. |
| Q39847750 | The incidence of bone metastasis after early-stage breast cancer in Canada |
| Q26849473 | Where Do Bone-Targeted Agents RANK in Breast Cancer Treatment? |
Search more.